363250 진시스템
기본 정보
- 섹터: KOSDAQ:제조
- 시가총액: 293억원 (2026-06-30 기준)
- 첫 등장: — (마커 미등장)
- 태그: 매크로/바이오헬스 · 분자진단 · PCR · 현장진단 · 진단키트
- 네이버 금융: 🔗
기업개요
- 동사는 2010년 설립되어 2021년 코스닥시장에 상장한 분자진단 전문기업임.
- 신속 PCR 기술 기반 현장 분자진단 플랫폼을 상용화하여 분자진단 시스템, 바이오칩, 검사키트 등을 개발·제조하며, 주요 제품을 유럽, 아시아 등 해외에 납품하고 있음.
- 코로나19 이후 개발도상국 시장 중심으로 사업을 확대하며, 검사 솔루션 다각화 및 Two-Track B2B 전략과 분자진단 기업들과의 제휴를 통한 사업확대를 추진하고 있음.
출처: 네이버증권 종목분석 (WiseReport)
일자별 등장 (최신 위, 누적)
| 일자 | 전일 종가 | 종가 | 등락률 | 시간외 | vol | 색깔 | smart | 외 | 연 | 금투 | 투 | 개 | 그외 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-14 | 4,075 | 4,070 | 🔵 -0.12% | — | ×0.2 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | +0.1 | +0.0 |
| 2026-08-13 | 4,415 | 4,075 | 🔵 -7.70% | — | ×0.9 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | +0.0 | -0.1 | +0.0 |
| 2026-08-12 | 4,365 | 4,415 | 🔴 +1.15% | — | ×0.5 | 🟢 외인 | +0.2억 | +0.2 | +0.0 | +0.0 | +0.0 | -0.2 | +0.0 |
| 2026-08-11 | 4,440 | 4,365 | 🔵 -1.69% | — | ×0.3 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | +0.1 | +0.0 |
| 2026-08-10 | 4,700 | 4,440 | 🔵 -5.53% | — | ×0.5 | 🟢 외인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | -0.0 | +0.0 |
| 2026-08-07 | 4,295 | 4,700 | 🔴 +9.43% | — | ×1.2 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | -0.0 | +0.0 | -0.1 | -0.0 |
| 2026-08-06 | 4,500 | 4,295 | 🔵 -4.56% | — | ×0.4 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | +0.1 | +0.0 |
| 2026-08-05 | 4,540 | 4,500 | 🔵 -0.88% | — | ×0.2 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | +0.0 | -0.1 | -0.0 |
| 2026-08-04 | 4,470 | 4,540 | 🔴 +1.57% | — | ×0.3 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.0 | +0.2 | -0.0 |
| 2026-08-03 | 4,730 | 4,470 | 🔵 -5.50% | — | ×0.5 | 🟡 금투 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-31 | 4,730 | 4,730 | ⚪ +0.00% | — | ×1.5 | 🔻 개인 | -0.3억 | -0.3 | +0.0 | +0.0 | +0.0 | +0.2 | +0.0 |
| 2026-07-30 | 4,280 | 4,730 | 🔴 +10.51% | — | ×1.4 | 🟢 외인 | +0.2억 | +0.2 | +0.0 | -0.0 | +0.0 | -0.2 | -0.0 |
| 2026-07-29 | 4,555 | 4,280 | 🔵 -6.04% | — | ×1.7 | 🔻 개인 | -0.5억 | -0.5 | +0.0 | +0.0 | +0.0 | +0.4 | +0.0 |
| 2026-07-28 | 4,010 | 4,555 | 🔴 +13.59% | — | ×7.0 | 🔻 개인 | -0.8억 | -0.8 | +0.0 | +0.0 | +0.0 | +0.8 | -0.0 |
| 2026-07-27 | 3,710 | 4,010 | 🔴 +8.09% | — | ×0.9 | 🟢 외인 | +0.2억 | +0.2 | +0.0 | +0.0 | +0.0 | -0.2 | +0.0 |
| 2026-07-24 | 3,590 | 3,710 | 🔴 +3.34% | — | ×0.5 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | +0.0 | -0.1 | +0.0 |
| 2026-07-23 | 3,580 | 3,590 | 🔴 +0.28% | — | ×0.5 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | +0.1 | +0.0 |
| 2026-07-22 | 3,685 | 3,580 | 🔵 -2.85% | — | ×0.7 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | +0.1 | +0.0 |
| 2026-07-21 | 3,510 | 3,685 | 🔴 +4.99% | — | ×1.1 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | +0.1 | +0.0 |
| 2026-07-20 | 3,405 | 3,510 | 🔴 +3.08% | — | ×1.6 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | +0.0 | -0.1 | +0.0 |
| 2026-07-16 | 3,415 | 3,405 | 🔵 -0.29% | — | ×1.2 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | -0.0 | +0.0 | +0.1 | +0.0 |
| 2026-07-15 | 3,010 | 3,415 | 🔴 +13.46% | — | ×2.6 | 🟢 외인 | +0.5억 | +0.5 | +0.0 | +0.0 | +0.0 | -0.6 | +0.0 |
| 2026-07-14 | 2,995 | 3,010 | 🔴 +0.50% | — | ×1.2 | 🟢 외인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | -0.0 | +0.0 |
| 2026-07-13 | 3,230 | 2,995 | 🔵 -7.28% | — | ×1.8 | 🟢 외인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | -0.0 | +0.0 |
| 2026-07-10 | 3,305 | 3,230 | 🔵 -2.27% | — | ×2.8 | 🟢 외인 | +0.2억 | +0.2 | +0.0 | +0.0 | +0.0 | -0.2 | +0.0 |
| 2026-07-09 | 3,375 | 3,305 | 🔵 -2.07% | — | ×0.6 | 🔻 개인 | -0.0억 | -0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-08 | 3,415 | 3,375 | 🔵 -1.17% | — | ×0.4 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | +0.1 | +0.0 |
| 2026-07-07 | 3,435 | 3,415 | 🔵 -0.58% | — | ×1.4 | 🔻 개인 | -0.3억 | -0.3 | +0.0 | +0.0 | +0.0 | +0.3 | +0.0 |
| 2026-07-06 | 3,255 | 3,435 | 🔴 +5.53% | — | ×1.0 | 🟢 외인 | +0.2억 | +0.2 | +0.0 | +0.0 | +0.0 | -0.2 | +0.0 |
| 2026-07-03 | 3,345 | 3,255 | 🔵 -2.69% | — | ×2.1 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | -0.0 | +0.0 | -0.1 | +0.0 |
| 2026-07-02 | 3,365 | 3,345 | 🔵 -0.59% | — | ×0.3 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | +0.1 | +0.0 |
| 2026-07-01 | 3,445 | 3,365 | 🔵 -2.32% | — | ×0.6 | 🔻 개인 | -0.0억 | -0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-06-30 | 3,475 | 3,445 | 🔵 -0.86% | — | ×0.8 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | +0.0 | -0.1 | +0.0 |
| 2026-06-29 | 3,485 | 3,475 | 🔵 -0.29% | — | ×0.7 | 🔻 개인 | -0.0억 | -0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-06-26 | 3,620 | 3,485 | 🔵 -3.73% | — | ×0.9 | 🔻 개인 | -0.0억 | -0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-06-25 | 3,625 | 3,620 | 🔵 -0.14% | — | ×0.4 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | +0.1 | +0.0 |
일자별 사유 (최신 위)
2026-07-30
- 사유: —
- 섹터 컨텍스트: KOSDAQ:제조 (smart +890억)
- 매크로 원인: 바이오헬스 매크로는 공통 테마 부재 — 개별 종목 이슈(거래재개·재료)로 각각 급등 (낮음)
2026-07-28
- 사유: —
- 섹터 컨텍스트: KOSDAQ:제조 (smart -216억)
- 매크로 원인: 코스닥 7.7% 급락장에서 개별 임상·실적 모멘텀 보유 바이오만 역행 급등 (보통)
2026-07-15
- 사유: —
- 섹터 컨텍스트: KOSDAQ:제조 (smart +1,144억)
- 매크로 원인: HLB 리보세라닙 FDA 제조 리스크 해소 기대에 그룹주 무더기 상한가, 미프진 허가 검토·항암신약 모멘텀 가세 (보통)